Peptide 'cognitive protocols' on TikTok: what the science says

What did @mikesheffer_ actually say?

He recommended five compounds for daily cognitive performance: BPC-157, Dihexa, Semax, Selank, and NAD+. The pitch was aimed at salespeople and high-pressure performers who deal with anxiety and need to "convey that message clearly." He called Dihexa "a 10 out of 10" for memory, described Selank as something that "smooths out that anxiety," and offered to DM followers the exact dosages he personally uses for each compound.

That last part is where this gets legally and medically complicated. Sharing individualized dosing protocols over TikTok DMs, for compounds that range from research-only to unapproved in the U.S., is not a casual wellness tip. It is the kind of thing that regulators have started paying close attention to. The framing around financial success also does a lot of work here, linking cognitive optimization to wealth in ways that are not scientifically supported by any of the research on these compounds.

Does the science back this up?

Partially, for some compounds, in animal models or very limited human data. The stack as a whole has never been studied together, and the "10 out of 10 every single day" framing has no clinical basis whatsoever.

BPC-157 has real preclinical data. Sikiric et al. (2018, Current Neuropharmacology) documented neuroprotective effects in rodent models, and there is some mechanistic reasoning behind the gut-brain axis claim. But there are no completed human clinical trials. Semax, a synthetic ACTH fragment developed in Russia, has shown cognitive effects in small studies, primarily from Russian-language literature, which has limited peer review reach in Western scientific databases. Selank has similarly limited but interesting anxiolytic data from animal studies and small Russian trials. NAD+ precursors have better human data, though most studies use NMN or NR orally, not IV NAD+ (Rajman et al., 2018, Cell Metabolism). Dihexa is the real outlier here, and not in a good way.

What did they get wrong (or right)?

The gut-brain axis point about BPC-157 is not wrong. There is legitimate mechanistic reasoning connecting gut inflammation to cognitive performance, and BPC-157 has shown anti-inflammatory effects in preclinical research. Credit where it is due.

But Dihexa is a serious concern. Developed at Washington State University by McCoy et al. (2013, Journal of Pharmacology and Experimental Therapeutics), it showed remarkable potency in rodent models, reportedly millions of times more potent than BDNF at stimulating HGF/c-Met signaling. What he did not mention: Dihexa has never completed human clinical trials, its safety profile in humans is essentially unknown, and it is not approved or regulated for human use in the U.S. Calling it "a 10 out of 10" without any human safety data is misleading at best. Similarly, Semax and Selank are not FDA-approved and are not legally sold as finished drug products in the United States, though some compounding pharmacies operate in gray areas. Presenting these as a casual daily stack glosses over significant regulatory and safety unknowns.

What should you actually know?

Most of these compounds exist in a regulatory gray zone that affects both safety and legality for consumers. That does not automatically mean they are dangerous, but it does mean the risk-benefit math is genuinely unknown for most of them in human populations.

A few things worth knowing before taking any of this at face value. First, peptides are not supplements. They are bioactive compounds that interact with receptors, cross biological barriers, and have dose-dependent effects that vary by individual. Second, stacking five of them simultaneously makes it nearly impossible to attribute effects or adverse reactions to any single compound. Third, getting dosing protocols from a social media DM, rather than a licensed clinician who knows your health history, is a real safety gap. Research on nootropic peptides is genuinely interesting and moving forward, but the jump from "promising in rodents" to "will make you perform like a millionaire" is not a small one. It is the entire gap between a hypothesis and a proven treatment.